|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansen JM, Coleman RL and Sood AK:
Targeting the tumour microenvironment in ovarian cancer. Eur J
Cancer. 56:131–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH
and Lee KH; Community of Population-Based Regional Cancer
Registries, : Cancer statistics in Korea: Incidence, mortality,
survival, and prevalence in 2014. Cancer Res Treat. 49:292–305.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smoliga JM, Baur JA and Hausenblas HA:
Resveratrol and health-a comprehensive review of human clinical
trials. Mol Nutr Food Res. 55:1129–1141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Riba A, Deres L, Sumegi B, Toth K,
Szabados E and Halmosi R: Cardioprotective effect of resveratrol in
a postinfarction heart failure model. Oxid Med Cell Longev.
2017:68192812017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chatterjee A, Ronghe A, Padhye SB, Spade
DA, Bhat NK and Bhat HK: Antioxidant activities of novel
resveratrol analogs in breast cancer. J Biochem Mol Toxicol.
322018.
|
|
7
|
Singh SK, Banerjee S, Acosta EP, Lillard
JW and Singh R: Resveratrol induces cell cycle arrest and apoptosis
with docetaxel in prostate cancer cells via a
p53/p21WAF1/CIP1 and p27KIP1 pathway.
Oncotarget. 8:17216–17228. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang X, Wang D and Zhao Y: Effect and
mechanism of resveratrol on the apoptosis of lung adenocarcinoma
cell line A549. Cell Biochem Biophys. 73:527–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gong WH, Zhao N, Zhang ZM, Zhang YX, Yan L
and Li JB: The inhibitory effect of resveratrol on COX-2 expression
in human colorectal cancer: A promising therapeutic strategy. Eur
Rev Med Pharmacol Sci. 21:1136–1143. 2017.PubMed/NCBI
|
|
10
|
Alobaedi OH, Talib WH and Basheti IA:
Antitumor effect of thymoquinone combined with resveratrol on mice
transplanted with breast cancer. Asian Pac J Trop Med. 10:400–408.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li P, Xu J, Wu X, Wu X, Guo Z, Fan L, Song
R, Wang J, Wei L and Teng H: Resveratrol attenuates high
glucose-induced nucleus pulposus cell apoptosis and senescence
through activating the ROS-mediated PI3K/Akt pathway. Biosci Rep.
38(pii): BSR201714542018.PubMed/NCBI
|
|
12
|
Hui Y, Chengyong T, Cheng L, Haixia H,
Yuanda Z and Weihua Y: Resveratrol attenuates the cytotoxicity
induced by amyloid-β1–42 in PC12 cells by upregulating heme
oxygenase-1 via the PI3K/Akt/Nrf2 pathway. Neurochem Res.
43:297–305. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hou Y, Feng S, Wang L, Zhao Z, Su J, Yin
X, Zheng N, Zhou X, Xia J and Wang Z: Inhibition of Notch-1 pathway
is involved in rottlerin-induced tumor suppressive function in
nasopharyngeal carcinoma cells. Oncotarget. 8:62120–62130. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang L, Sha J, Yang G, Huang X, Bo J and
Huang Y: Activation of Notch pathway is linked with
epithelial-mesenchymal transition in prostate cancer cells. Cell
Cycle. 16:999–1007. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bertelli AA and Das DK: Grapes, wines,
resveratrol, and heart health. J Cardiovasc Pharmacol. 54:468–476.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Piotrowska H, Myszkowski K, Ziolkowska A,
Kulcenty K, Wierzchowski M, Kaczmarek M, Murias M,
Kwiatkowska-Borowczyk E and Jodynis-Liebert J: Resveratrol analogue
3,4,4′,5-tetramethoxystilbene inhibits growth, arrests cell cycle
and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells.
Toxicol Appl Pharmacol. 263:53–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vergara D, De Domenico S, Tinelli A,
Stanca E, Del Mercato LL, Giudetti AM, Simeone P, Guazzelli N,
Lessi M, Manzini C, et al: Anticancer effects of novel resveratrol
analogues on human ovarian cancer cells. Mol Biosyst. 13:1131–1141.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Seino M, Okada M, Shibuya K, Seino S,
Suzuki S, Takeda H, Ohta T, Kurachi H and Kitanaka C: Differential
contribution of ROS to resveratrol-induced cell death and loss of
self-renewal capacity of ovarian cancer stem cells. Anticancer Res.
35:85–96. 2015.PubMed/NCBI
|
|
19
|
Sena LA and Chandel NS: Physiological
roles of mitochondrial reactive oxygen species. Mol Cell.
48:158–167. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xia N, Daiber A, Förstermann U and Li H:
Antioxidant effects of resveratrol in the cardiovascular system. Br
J Pharmacol. 174:1633–1646. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Heiss EH, Schilder YD and Dirsch VM:
Chronic treatment with resveratrol induces redox stress- and ataxia
telangiectasia-mutated (ATM)-dependent senescence in p53-positive
cancer cells. J Biol Chem. 282:26759–26766. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schilder YD, Heiss EH, Schachner D,
Ziegler J, Reznicek G, Sorescu D and Dirsch VM: NADPH oxidases 1
and 4 mediate cellular senescence induced by resveratrol in human
endothelial cells. Free Radic Biol Med. 46:1598–1606. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de la Lastra CA and Villegas I:
Resveratrol as an antioxidant and pro-oxidant agent: Mechanisms and
clinical implications. Biochem Soc Trans. 35:1156–1160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lang F, Qin Z, Li F, Zhang H, Fang Z and
Hao E: Apoptotic cell death induced by resveratrol is partially
mediated by the autophagy pathway in human ovarian cancer cells.
PLoS One. 10:e01291962015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang P, Li H, Yang B, Yang F, Zhang LL,
Kong QY, Chen XY, Wu ML and Liu J: Biological significance and
therapeutic implication of resveratrol-inhibited Wnt, Notch and
STAT3 signaling in cervical cancer cells. Genes Cancer. 5:154–164.
2014.PubMed/NCBI
|
|
26
|
Zheng XJ, Yang ZX, Dong YJ, Zhang GY, Sun
MF, An XK, Pan LH and Zhang SL: Downregulation of leptin inhibits
growth and induces apoptosis of lung cancer cells via the Notch and
JAK/STAT3 signaling pathways. Biol Open. 5:794–800. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SY, Kim MY, Mo JS and Park HS: Notch1
intracellular domain suppresses APP intracellular domain-Tip60-Fe65
complex mediated signaling through physical interaction. Biochim
Biophys Acta. 1773:736–746. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Coant N, Ben Mkaddem S, Pedruzzi E,
Guichard C, Tréton X, Ducroc R, Freund JN, Cazals-Hatem D, Bouhnik
Y, Woerther PL, et al: NADPH oxidase 1 modulates WNT and NOTCH1
signaling to control the fate of proliferative progenitor cells in
the colon. Mol Cell Biol. 30:2636–2650. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Steelman LS, Chappell WH, Abrams SL, Kempf
RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F,
Mazzarino MC, et al: Roles of the Raf/MEK/ERK and
PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity
to therapy-implications for cancer and aging. Aging (Albany NY).
3:192–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang Z, Liu Y, Shi C, Zhang Y, Lv R, Zhang
R, Wang Q and Wang Y: Suppression of PTEN/AKT signaling decreases
the expression of TUBB3 and TOP2A with subsequent inhibition of
cell growth and induction of apoptosis in human breast cancer MCF-7
cells via ATP and caspase-3 signaling pathways. Oncol Rep.
37:1011–1019. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rana C, Piplani H, Vaish V, Nehru B and
Sanyal SN: Downregulation of PI3-K/Akt/PTEN pathway and activation
of mitochondrial intrinsic apoptosis by diclofenac and curcumin in
colon cancer. Mol Cell Biochem. 402:225–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim DH, Kim MJ, Sung B, Suh H, Jung JH,
Chung HY and Kim ND: Resveratrol analogue, HS-1793, induces
apoptotic cell death and cell cycle arrest through downregulation
of AKT in human colon cancer cells. Oncol Rep. 37:281–288. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo D, Teng Q and Ji C: NOTCH and
phosphatidylinositide 3-kinase/phosphatase and tensin homolog
deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR)
signaling in T-cell development and T-cell acute lymphoblastic
leukemia. Leuk Lymphoma. 52:1200–1210. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cornejo MG, Mabialah V, Sykes SM, Khandan
T, Lo Celso C, Lopez CK, Rivera-Muñoz P, Rameau P, Tothova Z, Aster
JC, et al: Crosstalk between NOTCH and AKT signaling during murine
megakaryocyte lineage specification. Blood. 118:1264–1273. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang L, Jin F, Qin A, Hao Y, Dong Y, Ge S
and Dai K: Targeting Notch1 signaling pathway positively affects
the sensitivity of osteosarcoma to cisplatin by regulating the
expression and/or activity of Caspase family. Mol Cancer.
13:1392014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Lei J, Liu J, Ma F and Ju H: In
situ activation and monitoring of the evolution of the
intracellular caspase family. Chem Sci. 6:3365–3372. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mondal A and Bennett LL: Resveratrol
enhances the efficacy of sorafenib mediated apoptosis in human
breast cancer MCF7 cells through ROS, cell cycle inhibition,
caspase 3 and PARP cleavage. Biomed Pharmacother. 84:1906–1914.
2016. View Article : Google Scholar : PubMed/NCBI
|
